drugset

drugset / Trial / NCT01396226

A Multi-centre Study Comparing the Effects of AZD2927 and Placebo on the Electrical Activity in the Heart in Patients

NCT01396226 ↗

Phase 2 Completed 20 enrolled AstraZeneca

RandomizedParallel-groupDouble-blindBasic science

Summary

Medical Products Agency

Timeline

Start: 2011-09
Primary completion: 2012-01
Completion: 2012-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	AZD2927	Small molecule	—	Intravenous

Indications